Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BIIB:US

401.710 USD 28.570 6.64%

As of 20:10:00 ET on 04/24/2015.

Snapshot for Biogen Inc (BIIB)

Open: 410.000 Day's Range: 395.000 - 410.870 Volume: 6,084,406
Previous Close: 430.280 52wk Range: 275.392 - 480.180 1-Yr Rtn: +40.55%

Stock Chart for BIIB

No chart data available.
  • BIIB:US 402.005
  • 1D
  • 1M
  • 1Y
430.280
Interactive BIIB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIIB

Current P/E Ratio (ttm) 29.2840
Estimated P/E(12/2015) 23.7417
Relative P/E vs. SPX 1.5668
Earnings Per Share (USD) (ttm) 13.7177
Est. EPS (USD) (12/2015) 16.9200
Est. PEG Ratio 1.3894
Market Cap (M USD) 94,494.05
Shares Outstanding (M) 235.23
30 Day Average Volume 2,337,662
Price/Book (mrq) 8.0764
Price/Sale (ttm) 9.3530
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/23/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIIB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BIIB

Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOAdriana Karaboutis "Andi"Exec VP:Tech & Bus Solutions
More Company Profile & Key Executives for BIIB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil